Monday, December 12, 2016

BRIEF-Imugene to acquire immuno-oncology technology from Baker IDI institute

* Imugene broadens pipeline with acquisition of

immuno-oncology technology from Melbourne's Baker IDI heart and

diabetes institute

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)